➡️ u.afp.com/SHPh
➡️ u.afp.com/SHPh
ExplorerVacations.com
Cagliari, Sardinia 🇮🇹 Sun-kissed streets, ancient history, and sweeping sea views—this coastal gem stole our hearts. 🌊✨
#Cagliari #Sardinia #Italy #ExplorerVacations
For travel guides, visit: www.theroyaltourblog.com
ExplorerVacations.com
Cagliari, Sardinia 🇮🇹 Sun-kissed streets, ancient history, and sweeping sea views—this coastal gem stole our hearts. 🌊✨
#Cagliari #Sardinia #Italy #ExplorerVacations
For travel guides, visit: www.theroyaltourblog.com
#BestSongHeardToday
27/11
(331/365)
Dreams
TV On The Radio | 2004
It was twenty years ago...
youtube.com/watch?v=shPH...
#BestSongHeardToday
27/11
(331/365)
Dreams
TV On The Radio | 2004
It was twenty years ago...
youtube.com/watch?v=shPH...
https://www.stocktitan.net/news/SHPH/united-dogecoin-purchases-dogecoin-miners-and-secures-renewable-knzixnsustlf.html
https://www.stocktitan.net/news/SHPH/united-dogecoin-purchases-dogecoin-miners-and-secures-renewable-knzixnsustlf.html
https://www.stocktitan.net/news/SHPH/shuttle-pharma-provides-corporate-update-and-reports-2024-pt9vzb5nyrxi.html
https://www.stocktitan.net/news/SHPH/shuttle-pharma-provides-corporate-update-and-reports-2024-pt9vzb5nyrxi.html
This is a speculative shell — a clinical-stage cancer biotech with an AI-powered molecular discovery platform. Tiny market cap, history of reverse splits and dilutions, and a brutal downtrend.
This is a speculative shell — a clinical-stage cancer biotech with an AI-powered molecular discovery platform. Tiny market cap, history of reverse splits and dilutions, and a brutal downtrend.
https://www.stocktitan.net/news/SHPH/shuttle-pharmaceuticals-holdings-inc-announces-receipt-of-nasdaq-9fmewdti0lbp.html
https://www.stocktitan.net/news/SHPH/shuttle-pharmaceuticals-holdings-inc-announces-receipt-of-nasdaq-9fmewdti0lbp.html
www.biopharmcatalyst.com/news/2025/q3...
www.biopharmcatalyst.com/news/2025/q3...
www.biopharmcatalyst.com/news/2026/at...
www.biopharmcatalyst.com/news/2026/at...
Raquel Welch in Mexico City. #CDMX
www.youtube.com/watch?v=ShpH...
Raquel Welch in Mexico City. #CDMX
www.youtube.com/watch?v=ShpH...
finance.yahoo.com/news/shuttle...
finance.yahoo.com/news/shuttle...
www.biopharmcatalyst.com/news/2026/ne...
www.biopharmcatalyst.com/news/2026/ne...
www.youtube.com/watch?v=shpH...
www.youtube.com/watch?v=shpH...
(d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned her...
(d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned her...
As previously disclosed, on September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. held a Special Meeting of Stockholders pursuant to which, among other things, the stockholders of the Company approved the issuance of securities of the Company as described in that Definitive Proxy Stat...
As previously disclosed, on September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. held a Special Meeting of Stockholders pursuant to which, among other things, the stockholders of the Company approved the issuance of securities of the Company as described in that Definitive Proxy Stat...
On September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. held a Special Meeting of Stockholders . As of August 6, 2026, the record date for the Meeting, 1,027,214 shares of the Company’s common stock, par value $0.00001 per share , were issued and outstanding, with each share entitled...
On September 9, 2026, Shuttle Pharmaceuticals Holdings, Inc. held a Special Meeting of Stockholders . As of August 6, 2026, the record date for the Meeting, 1,027,214 shares of the Company’s common stock, par value $0.00001 per share , were issued and outstanding, with each share entitled...